Recombinant Cell Culture Supplements Market

Global Market Study on Recombinant Cell Culture Supplements: Increasing Clinical Research Activities in Developing Regions Aiding Market Growth

  • March-2020
  • PMRREP31310
  • 309 Pages
  • Healthcare


In recent years, biopharmaceutical companies have become increasingly dependent on contract research organizations (CROs) for their research & development operations.

Clinical trials and research is now a major business in India, owing to numerous governmental-funded medical and pharmaceutical institutions with state-of-the-art facilities. India has allowed 100% Foreign Direct Investment (FDI) in clinical trials, which has attracted many companies to enter the Indian market.

Research & development costs in India and China are considerably lesser as compared to those in developed countries, which will help boost the growth of the recombinant cell culture supplements market.

Find Out More about the Report Coverage


  • Thermo Fisher Scientific
  • Merck KGaA
  • Lonza Group AG
  • F. Hoffmann-La Roche AG
  • Abcam PLC.
  • Hi-Media Laboratories
  • Becton, Dickinson and Company
  • STEMCELL Technologies Inc.
  • Fujifilm Corporation (Irvine Scientific)
  • InVitria (Ventria Bioscience)
  • Biocon
  • Cell Sciences, Inc.

Increasing Demand for Animal-free Recombinant Cell Culture Supplements

Key stakeholders in the cell culture market are focusing on the introduction of animal-free recombinant cell culture supplements. Animal-free products eliminate the risk of contaminating cell culture media. They are manufactured using all human production systems or microorganisms.

No animal-derived cells are used in the manufacturing of cell culture supplements. Growing adoption of animal-free products in various research applications is expected to propel the growth of the global recombinant cell culture supplements market over the coming years.

Customize this Report

Explore Intelligence Tailored to Your Business Goals.

Market Players Focusing on Enhancement of Sales and Distribution Network

Strong distribution network is essential, as most players in the global recombinant cell culture supplements market have limited regional presence, and make their products available around the world using numerous retailers and distributors.

Small companies in the recombinant cell culture supplements market, such as Cell Applications, Inc., have offices and manufacturing support in limited locations.

However, they make their products available globally through an extensive distributor network. Roche signed an agreement with Merck for the distribution of its recombinant cell culture supplement products in 2019.

Market Research Methodology - Perfected through Years of Diligence

A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.

Get actionable insights on Ship Repair And Maintenance Services Market

Increasing Focus on Oncological Research to Create Demand for Customized Recombinant Cell Culture Supplements

Recombinant cell culture supplements are an integral part of cancer research. The connection between recombinant growth factors and oncogenes has led to a better understanding of carcinogenesis and providing newer targets for chemotherapy. 

Recombinant growth factors such as vascular epithelial growth factors, epidermal growth factors, fibroblast growth factors, and platelet-driven growth factors have an important role in cancer research, For example, Hoffmann-La Roche Ltd focuses its research on cancer and other prevailing diseases such as diabetes using cell culture.

The National Cancer Institute (NCI), along with other institutes, invests in major research initiatives to facilitate and support cancer research.

recombinant cell culture supplements market

Explore Persistence Market Research’s expertise in promulgation of the business !

North America and Europe to Lead Recombinant Cell Culture Supplements Market

North America and Europe, together, hold around 65% share of the global recombinant cell culture supplements market. Increase in demand for cell culture products from biopharmaceutical companies, cancer research institutes, and others will drive the recombinant cell culture supplements market in these regions.

Increasing funding for cell culture research and pipeline of biologics by major players in these regions would further drive the recombinant cell culture supplements market.

Competitive Landscape of Recombinant Cell Culture Supplements Market

Key players operating in recombinant cell culture supplements market across the globe include Thermo Fisher Scientific, Merck KGaA, Hoffmann-La Roche Ltd, Lonza Group Ltd, and FUJIFILM Holdings Corporation, among others.  Manufacturers are focusing on mergers, acquisitions, expansion, and key partnerships to expand their product portfolio and increase revenue across different geographies.

For instance, in October 2018, Thermo Fisher Scientific completed the acquisition of Becton Dickinson and Company’s advanced bioprocessing business, to add cell culture products that will expand the bio-production product portfolio of the company in the recombinant cell culture supplements market.

Moreover, manufacturers are focusing on expansion & advancement of production facilities to produce custom vaccines. For instance, in August 2016, Merck opened a new pharmaceutical manufacturing plant in Nantong, China. This strategic investment further supports Merck’s expansion in the global recombinant cell culture supplements market.

Analysts’ Viewpoint

The research report on the recombinant cell culture supplements market provides recommendations, overview of the market, and estimation of market growth over the next decade. Increment in the number of biopharmaceutical manufacturers and increasing life research investments are responsible for the growth of the recombinant cell culture supplements market. Increasing prevalence of diseases such as cancer and diabetes, across the world, and development of novel biologics will favor the growth of the global recombinant cell culture supplements market in the years to come.

Media Release

Our Clients

Our Clients